We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
701
Ostrum Asset Management
France
$2.33M +$172K +1,663 +7%
TWM
702
TriaGen Wealth Management
California
$2.32M -$4.76K -46 -0.2%
GLR
703
Great Lakes Retirement
Ohio
$2.3M +$61.9K +598 +3%
ACM
704
Anfield Capital Management
California
$2.3M +$2.44M +23,525 New
SAM
705
Smartleaf Asset Management
Massachusetts
$2.29M +$626K +6,049 +35%
PS
706
Principal Securities
Iowa
$2.28M +$576K +5,564 +31%
KeyBank National Association
707
KeyBank National Association
Ohio
$2.27M +$724K +6,992 +43%
MFS
708
Mattson Financial Services
Michigan
$2.25M +$138K +1,335 +6%
SWM
709
Spire Wealth Management
Virginia
$2.25M +$408K +3,941 +21%
SCA
710
Snowden Capital Advisors
New York
$2.24M +$264K +2,551 +13%
WR
711
WD Rutherford
Oregon
$2.23M +$664K +6,414 +39%
FRM
712
Fox Run Management
Connecticut
$2.21M +$2.34M +22,606 New
VFA
713
Valeo Financial Advisors
Indiana
$2.21M +$4.66K +45 +0.2%
FC
714
Farringdon Capital
United Kingdom
$2.2M +$2.34M +22,570 New
QPBE
715
Quintet Private Bank (Europe)
Luxembourg
$2.18M -$31.1K -300 -1%
SWP
716
Stratos Wealth Partners
Ohio
$2.17M +$267K +2,582 +13%
ECM
717
Eisler Capital Management
United Kingdom
$2.17M +$1.68M +16,194 +261%
AAM
718
Azzad Asset Management
Virginia
$2.16M -$43.3K -418 -2%
SAM
719
Sectoral Asset Management
Quebec, Canada
$2.16M +$104K +1,000 +5%
PIMJS
720
PKO Investment Management Joint-Stock
Poland
$2.15M +$932K +9,000 +69%
SC
721
Stance Capital
Massachusetts
$2.15M +$1.96M +18,915 +614%
IWC
722
Integrated Wealth Concepts
Massachusetts
$2.14M -$21.5K -208 -0.9%
SFP
723
Shepherd Financial Partners
Massachusetts
$2.14M -$621 -6 -0%
PWG
724
Portside Wealth Group
Utah
$2.13M +$2.26M +21,859 New
SAI
725
Systematic Alpha Investments
New Jersey
$2.12M

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.